I131Iobenguane_CommercialRadioligandProductMap
I
ℹ️ Utility checks critical parameters of I-131 MIBG radiopharmaceutical:
• Total Activity: Within specification
• Radiochemical Purity: ≥95.0%
• Free Iodide-131: ≤5.0%
• Chemical Purity: ≥98.0%
• pH: 4.0–7.0
• Endotoxins: ≤175 EU/mL
• Sterility: Mandatory
• Specific Activity: >10 MBq/mcg
⚠️ CRITICAL: High level of free iodide leads to accumulation in the thyroid gland.
Radiochemical purity is critical for image quality and radiation dose.
Usage:
I131Iobenguane_CommercialRadioligandProductMap.exe → demo mode
I131Iobenguane_CommercialRadioligandProductMap.exe input.csv output.json → evaluate data
Input format:
BatchNumber,TotalActivityMBq,RCP,FreeIodide,ChemPurity,pH,Endotoxins,Sterility,SpecificActivity
Example (sterility: 0=sterile):
I131-MIBG-2026-001,3700.0,98.5,1.2,99.5,5.5,50.0,0,50.0
— WHY IS THIS NEEDED?
Iodine-131 iobenguane (MIBG) is used for diagnosis and treatment of neuroendocrine tumors:
• Norepinephrine analog, accumulates in sympathetic nervous tissue
• I-131 emits beta particles (therapy) and gamma rays (diagnosis)
• Requires high radiochemical purity to minimize thyroid dose
• Free iodide is the main impurity formed during radiolysis
⚠️ CRITICAL:
• Radiochemical Purity ≥95.0% — ensures radionuclide delivery to target
• Free Iodide-131 ≤5.0% — critical! Accumulation in thyroid causes radiation damage
• Chemical Purity ≥98.0% — absence of toxic chemical impurities
• pH 4.0–7.0 — product stability and blood compatibility
• Endotoxins ≤175 EU/mL — safety for IV administration
• Sterility — mandatory for all parenteral forms
• Specific Activity — sufficient radioactivity per mass of substance
Key features:
• Radiochemical purity control (main QC parameter for RFP)
• Monitoring of free iodide as critical impurity
• Assessment of chemical purity of inactive carrier
• Safety check (endotoxins, sterility)
Critical parameters:
• Total Activity: Label Claim +/- 10%
• Radiochemical Purity: ≥95.0%
• Free Iodide-131: ≤5.0%
• Chemical Purity: ≥98.0%
• pH: 4.0–7.0
• Endotoxins: ≤175 EU/mL
• Sterility: Sterile
• Specific Activity: >10 MBq/mcg
💡 Usage tips:
1. Radiochemical purity determined by TLC or HPLC with radio-detector
2. Free iodide controlled simultaneously with RCP
3. Product requires light protection (iodine is sensitive to photolysis)
4. Store at 2-8°C
5. Check vial integrity and activity before use
6. If high level of free iodide detected, patient must receive thyroid blockers (potassium perchlorate)
⚠️ Note: I-131 has a long half-life (8 days), allowing therapeutic use. However, this also means prolonged patient irradiation in presence of impurities. Therefore, free iodide control is the most important safety aspect of this product. Radiolysis can increase free iodide fraction over time, so shelf life after preparation is limited.
input.csv
BatchNumber,TotalActivityMBq,RCP,FreeIodide,ChemPurity,pH,Endotoxins,Sterility,SpecificActivity I131-MIBG-2026-001,3700.0,98.5,1.2,99.5,5.5,50.0,0,50.0 I131-MIBG-2026-002,3500.0,96.0,3.5,99.0,6.0,40.0,0,45.0
I131Iobenguane_CommercialRadioligandProductMap — Documentation
input.csv and *.description.txt. Package folder: Global/API coverage extension.Utility description
I-131 Iobenguane Commercial Radioligand Product Map — I-131 MIBG Radiopharmaceutical Quality Control
ℹ️ Utility checks critical parameters of I-131 MIBG radiopharmaceutical:
• Total Activity: Within specification
• Radiochemical Purity: ≥95.0%
• Free Iodide-131: ≤5.0%
• Chemical Purity: ≥98.0%
• pH: 4.0–7.0
• Endotoxins: ≤175 EU/mL
• Sterility: Mandatory
• Specific Activity: >10 MBq/mcg
⚠️ CRITICAL: High level of free iodide leads to accumulation in the thyroid gland.
Radiochemical purity is critical for image quality and radiation dose.
Usage:
I131Iobenguane_CommercialRadioligandProductMap.exe → demo mode
I131Iobenguane_CommercialRadioligandProductMap.exe input.csv output.json → evaluate data
Input format:
BatchNumber,TotalActivityMBq,RCP,FreeIodide,ChemPurity,pH,Endotoxins,Sterility,SpecificActivity
Example (sterility: 0=sterile):
I131-MIBG-2026-001,3700.0,98.5,1.2,99.5,5.5,50.0,0,50.0
— WHY IS THIS NEEDED?
Iodine-131 iobenguane (MIBG) is used for diagnosis and treatment of neuroendocrine tumors:
• Norepinephrine analog, accumulates in sympathetic nervous tissue
• I-131 emits beta particles (therapy) and gamma rays (diagnosis)
• Requires high radiochemical purity to minimize thyroid dose
• Free iodide is the main impurity formed during radiolysis
⚠️ CRITICAL:
• Radiochemical Purity ≥95.0% — ensures radionuclide delivery to target
• Free Iodide-131 ≤5.0% — critical! Accumulation in thyroid causes radiation damage
• Chemical Purity ≥98.0% — absence of toxic chemical impurities
• pH 4.0–7.0 — product stability and blood compatibility
• Endotoxins ≤175 EU/mL — safety for IV administration
• Sterility — mandatory for all parenteral forms
• Specific Activity — sufficient radioactivity per mass of substance
Key features:
• Radiochemical purity control (main QC parameter for RFP)
• Monitoring of free iodide as critical impurity
• Assessment of chemical purity of inactive carrier
• Safety check (endotoxins, sterility)
Critical parameters:
• Total Activity: Label Claim +/- 10%
• Radiochemical Purity: ≥95.0%
• Free Iodide-131: ≤5.0%
• Chemical Purity: ≥98.0%
• pH: 4.0–7.0
• Endotoxins: ≤175 EU/mL
• Sterility: Sterile
• Specific Activity: >10 MBq/mcg
💡 Usage tips:
1. Radiochemical purity determined by TLC or HPLC with radio-detector
2. Free iodide controlled simultaneously with RCP
3. Product requires light protection (iodine is sensitive to photolysis)
4. Store at 2-8°C
5. Check vial integrity and activity before use
6. If high level of free iodide detected, patient must receive thyroid blockers (potassium perchlorate)
⚠️ Note: I-131 has a long half-life (8 days), allowing therapeutic use. However, this also means prolonged patient irradiation in presence of impurities. Therefore, free iodide control is the most important safety aspect of this product. Radiolysis can increase free iodide fraction over time, so shelf life after preparation is limited.URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of I131Iobenguane_CommercialRadioligandProductMap for I.
Portal packages
Global/API coverage extension, LabEx QC laboratory utilities, Lumex QC instrument utilities, Radiology QC Suite, Combined Radiopharma QC Suite, World API/FDC extension
CSV→JSONFDCMissingAPIQCRPHRadioligandRadiologyRadiopharmaURS & FSP2Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of I-131 MIBG radiopharmaceutical:
- • Total Activity: Within specification
- • Radiochemical Purity: ≥95.0%
- • Free Iodide-131: ≤5.0%
- • Chemical Purity: ≥98.0%
- • Endotoxins: ≤175 EU/mL
- • Sterility: Mandatory
- ⚠️ CRITICAL: High level of free iodide leads to accumulation in the thyroid gland.
- Radiochemical purity is critical for image quality and radiation dose.
- BatchNumber,TotalActivityMBq,RCP,FreeIodide,ChemPurity,pH,Endotoxins,Sterility,SpecificActivity
- Example (sterility: 0=sterile):
- • Free iodide is the main impurity formed during radiolysis
- ⚠️ CRITICAL:
- • Radiochemical Purity ≥95.0% — ensures radionuclide delivery to target
- • Free Iodide-131 ≤5.0% — critical! Accumulation in thyroid causes radiation damage
- • Chemical Purity ≥98.0% — absence of toxic chemical impurities
- • pH 4.0–7.0 — product stability and blood compatibility
- • Endotoxins ≤175 EU/mL — safety for IV administration
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file for I with headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions. | High | Identical input data, rule version and configuration produce reproducible results. |
| URS-003 | The utility shall validate mandatory fields, data types, ranges, units and domain plausibility. | High | Schema, conversion and range errors are explicitly reported. |
| URS-004 | The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs. | High | Each check has PASS/WARNING/FAIL and a clear message. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall preserve traceability between batch/sample, input file, applied rules and final status. | High | Output contains identifiers, checked parameters and audit metadata. |
| URS-007 | The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors. | Medium | URS, FS, input/output contract and test scenarios are supplied with the utility. |
| URS-008 | The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision. | Medium | Documentation states change control and limit-verification expectations. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string / controlled vocabulary | I131-MIBG-2026-001 | Batch or lot identifier used for traceability. |
| 2 | TotalActivityMBq | decimal | 3700.0 | Controlled input parameter for deterministic QC rules. |
| 3 | RCP | decimal | 98.5 | Controlled input parameter for deterministic QC rules. |
| 4 | FreeIodide | decimal | 1.2 | Controlled input parameter for deterministic QC rules. |
| 5 | ChemPurity | decimal | 99.5 | Controlled input parameter for deterministic QC rules. |
| 6 | pH | decimal | 5.5 | pH; parameter relevant to stability, compatibility and batch suitability. |
| 7 | Endotoxins | decimal | 50.0 | Microbiological/endotoxin parameter relevant to safety. |
| 8 | Sterility | decimal | 0 | Microbiological/endotoxin parameter relevant to safety. |
| 9 | SpecificActivity | decimal | 50.0 | Controlled input parameter for deterministic QC rules. |
BatchNumber,TotalActivityMBq,RCP,FreeIodide,ChemPurity,pH,Endotoxins,Sterility,SpecificActivity I131-MIBG-2026-001,3700.0,98.5,1.2,99.5,5.5,50.0,0,50.0 I131-MIBG-2026-002,3500.0,96.0,3.5,99.0,6.0,40.0,0,45.0
Input validation rules
| ID | Field | Rule | Criticality |
|---|---|---|---|
| VR-001 | BatchNumber | The field shall match an approved dictionary or accepted string representation. | High |
| VR-002 | TotalActivityMBq | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-003 | RCP | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-004 | FreeIodide | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
| VR-005 | ChemPurity | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
| VR-006 | pH | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
| VR-007 | Endotoxins | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-008 | Sterility | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-009 | SpecificActivity | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CLI execution | Support execution modes: demo mode without arguments and production mode input.csv output.json. |
| FS-002 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate header and expected columns. |
| FS-003 | Schema validation | Check mandatory fields, column count, unknown key fields and empty mandatory values. |
| FS-004 | Type conversion | Convert numeric, flag and text values; invalid format is recorded as a row-level error. |
| FS-005 | Domain rule engine | Apply rules for I, including critical limits from the description and approved specification. |
| FS-006 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-007 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-008 | Audit support | Keep result structure suitable for review, deviation investigation and calculation reproduction. |
| FS-009 | Integration contract | Support the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review. |
| FS-010 | Fallback mapping | For a single API or modality, use this specialized utility together with applicable Lumex/LabEx instrumental checks. |
| FS-011 | Error handling | Return explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format. |
Example output.json
{
"utilityId": "i-131-iobenguane-commercial-radioligand-product-map",
"utilityFolder": "I131Iobenguane_CommercialRadioligandProductMap",
"package": "Global/API coverage extension",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"processedAtUtc": "2026-07-02T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "I131-MIBG-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-001"
},
{
"parameter": "TotalActivityMBq",
"value": "3700.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-002"
},
{
"parameter": "RCP",
"value": "98.5",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-003"
},
{
"parameter": "FreeIodide",
"value": "1.2",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-004"
},
{
"parameter": "ChemPurity",
"value": "99.5",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-005"
},
{
"parameter": "pH",
"value": "5.5",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-006"
},
{
"parameter": "Endotoxins",
"value": "50.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-007"
},
{
"parameter": "Sterility",
"value": "0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-008"
},
{
"parameter": "SpecificActivity",
"value": "50.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-009"
}
],
"criticalFindings": [],
"warnings": [],
"audit": {
"inputHash": "sha256:<calculated at runtime>",
"rulesVersion": "<utility executable version>",
"documentation": "I131Iobenguane_CommercialRadioligandProductMap.documentation.html"
}
}
Traceability matrix
| URS | FS | Test | Evidence |
|---|---|---|---|
| URS-001 | FS-001, FS-002 | OQ-001 | Verify execution and import of valid input.csv. |
| URS-002 | FS-005, FS-006 | OQ-004 | Repeat the same dataset and compare output.json. |
| URS-003 | FS-003, FS-004, FS-011 | OQ-002, OQ-003 | Verify missing columns and invalid types. |
| URS-004 | FS-005, FS-006 | OQ-004, PQ-001 | Verify critical deviations on real/boundary data. |
| URS-005 | FS-007, FS-009 | OQ-005 | Verify JSON schema and downstream-system suitability. |
| URS-006 | FS-008 | OQ-006 | Verify identifiers and audit metadata. |
| URS-007 | FS-008, FS-011 | IQ-001, OQ-007 | Verify documentation completeness and control evidence. |
| URS-008 | FS-005, FS-008, FS-010 | PQ-002 | Verify review workflow and no replacement of QA decision. |
IQ/OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| IQ-001 | Verify executable, input.csv, documentation and checksum availability. | Delivery set is complete; version is recorded. |
| OQ-001 | Valid sample row from input.csv. | PASS or acceptable WARNING according to rules. |
| OQ-002 | Remove a mandatory CSV column. | Schema error or FAIL with missing-column reference. |
| OQ-003 | Place a non-numeric value into a numeric field. | Type-conversion error with row/field reference. |
| OQ-004 | Set a critical parameter outside the limit. | FAIL and critical finding. |
| OQ-005 | Verify output.json structure. | All mandatory sections are present and JSON is valid. |
| OQ-006 | Verify batch/sample traceability. | Input and result identifiers match. |
| OQ-007 | Verify fallback/decomposition for combined APIs. | Component checks are explicitly documented. |
| PQ-001 | Verify 3–5 real user batches/samples. | Result is confirmed by QC/QA review. |
| PQ-002 | Verify deviation workflow and manual QA decision. | Utility supports review but does not replace approved decision. |
QA/QC and change control
- Do not rename columns without updating validator, documentation and test set.
- Retain input.csv, output.json, executable version and checksum.
- Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
- For combination products, document whether the specialized FDC utility or fallback component checks were used.
- The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.
Included in packages
Global API & Biosimilars QC Suite
Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.
OpenRadiology QC Suite
QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.
OpenRPH isotope family: radioiodine
I-123, I-124, I-125 and I-131 for diagnostics, therapy, labelling and purity control.
OpenRPH organ/system: brain and CNS
Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.
OpenRPH organ/system: endocrine, thyroid and NET
Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.
OpenRPH organ/system: hepatobiliary and GI
HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.
OpenRPH organ/system: oncology and theranostics
Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
OpenRPH use case: radionuclide therapy and theranostics
Lu-177, Ac-225, Ra-223, Y-90, Ho-166, Sm-153, Sr-89, Re-188, Tb-161, I-131 and other therapeutic radiopharmaceuticals: activity, purity, free metal, daughters and toxicological constraints.
OpenRPH workflow: instruments, devices and radiation safety
PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH workflow: stability, storage, decay and waste
Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.
OpenRPH: combined radiopharmaceutical QC package
RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.
OpenWorld API Extension QC Suite
Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.
Open